Syneron Medical Ltd. Launches High Power VelaShape(TM) for Faster Cellulite Treatment and Circumferential Reduction

YOKNEAM, ISRAEL--(MARKET WIRE)--Aug 23, 2007 -- Syneron(TM) Medical Ltd. (NasdaqGS:ELOS - News), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today introduces the VelaShape(TM). VelaShape is the newest addition to Syneron’s Vela(TM) platform of non-invasive devices for body treatment. The VelaShape device has received US Food and Drug Administration (FDA) 510(k) pre-marketing clearance for the temporary reduction of the appearance of cellulite, as well as temporary reduction of thigh circumference.

MORE ON THIS TOPIC